Read + Share
Kelsey MD, Newby LK. In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality. Ann Intern Med 2022;175:JC26.
PMID: 35226528
|
 |
|
Kelsey MD, Newby LK. In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality. Ann Intern Med 2022;175:JC26.
PMID: 35226528
|
|
|
|